Top

Endocrine

Published in:

01-07-2018 | Editorial

Thyroid cancer-related bone metastases: increasingly good prospects for treatment

Author: Leonidas H. Duntas

Published in: Endocrine | Issue 1/2018

Excerpt

Medicine starts with the patient, continues with the patient and ends with the patient.

…

J. Wexler, Bone metastases from differentiated thyroid carcinoma. in Thyroid Cancer, ed. by L. Wartofsky, D. Van Nostrand (New York: Springer, 2016), pp. 723-733)..

M. Schlumberger, C. Challeton, F. De Vathaire, J.P. Travagli, P. Gardet, J.D. Lumbroso, C. Francese, F. Fontaine, M. Ricard, C. Parmentier, Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J. Nucl. Med. 37, 598–605 (1996)PubMed

A.C. Chiu, E.S. Delpassand, S.I. Sherman, Prognosis and treatment of brain metastases in thyroid carcinoma. J. Clin. Endocrinol. Metab. 82, 3637–3642 (1997)CrossRefPubMed

P. Choksi, M. Papaleontiou, C. Guo, F. Worden, M. Banerjee, M. Haymart, Skeletal complications and mortality in thyroid cancer: a population-based study. J. Clin. Endocrinol. Metab. 102, 1254–1260 (2017). https://doi.org/10.1210/jc.2016-3906 CrossRefPubMedPubMedCentral

A.F. Mavrogenis, A. Angelini, C. Vottis, E. Pala, T. Calabrò, P.J. Papagelopoulos, P. Ruggieri, Modern palliative treatments for metastatic bone disease: awareness of advantages, disadvantages, and guidance. Clin. J. Pain. 32, 337–350 (2016). https://doi.org/10.1097/AJP.0000000000000255 CrossRefPubMed

G. Rossi, A.F. Mavrogenis, E. Rimondi, L. Braccaioli, T. Calabrò, P. Ruggieri, Selective embolization with N-butyl cyanoacrylate for metastatic bone disease. J. Vasc. Interv. Radiol. 22, 462–470 (2011). https://doi.org/10.1016/j.jvir.2010.12.023 CrossRefPubMed

B.H. Lang, K.P. Wong, C.Y. Cheung, K.Y. Wan, C.Y. Lo, Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis. Ann. Surg. Oncol. 4, 1329–1335 (2013). https://doi.org/10.1245/s10434-012-2711-x CrossRef

G. Mazziotti, A.M. Formenti, M.B. Panarotto, E. Arvat, A. Chiti, A. Cuocolo, M.E. Dottorini, C. Durante, L. Agate, S. Filetti, F. Felicetti, A. Filice, L. Pace, T. Pellegrino, M. Rodari, M. Salvatori, C. Tranfaglia, A. Versari, D. Viola, S. Frara, A. Berruti, A. Giustina, R. Giubbini, Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience. Endocrine 59, 90–101 (2018). https://doi.org/10.1007/s12020-017-1455-6 CrossRefPubMed

C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl, J.P. Travagli, B. Caillou, M. Ricard, J.D. Lumbroso, F. De Vathaire, M. Schlumberger, Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J. Clin. Endocrinol. Metab. 8, 2892–2899 (2006)CrossRef

10.

Z.L. Qiu, H.J. Song, Y.H. Xu, Q.Y. Luo, Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 96, 3078–3086 (2011). https://doi.org/10.1210/jc.2011-0093 CrossRefPubMed

11.

M.T. Drake, J.N. Farr, Inhibitors of sclerostin: emerging concepts. Curr. Opin. Rheumatol. 26, 447–452 (2014). https://doi.org/10.1097/BOR.0000000000000073 CrossRefPubMedPubMedCentral

12.

S. Sousa, P. Clézardin, Bone-targeted therapies in cancer-induced bone disease. Calcif. Tissue Int. 102, 227–250 (2018). https://doi.org/10.1007/s00223-017-0353-5 CrossRefPubMed

13.

H. Jadvar, Targeted radionuclide therapy: An evolution toward precision cancer treatment. Ajr. Am. J. Roentgenol. 209, 277–288 (2017). https://doi.org/10.2214/AJR.17.18264 CrossRefPubMedPubMedCentral

Title: Thyroid cancer-related bone metastases: increasingly good prospects for treatment
Author: Leonidas H. Duntas
Publication date: 01-07-2018
Publisher: Springer US
Published in: Endocrine / Issue 1/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-018-1616-2

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2018

Adding metyrapone to chemotherapy plus mitotane for Cushing’s syndrome due to advanced adrenocortical carcinoma

Practical issues for the management of hyponatremia in oncology

Physiopathological relationship between chronic obstructive pulmonary disease and insulin resistance

Comment on Microsurgical therapy of pituitary adenomas

Remembering Professor Gaetano “Nino” Salvatore

Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage